ExellenS™

ExellenS™ is Samsung Biologics’ standardized biomanufacturing
framework
, applied consistently across Bio Campus I and Bio Campus II
to ensure plant-to-plant equivalency and speed.
The framework combines biologics and technological expertise to
eliminate inefficiencies resulting in faster, more predictable processes
and consistent delivery across programs. Related capabilities can be
explored through Biopharma Manufacturing.

ExellenS™ Aspired.
With unmatched plant equivalency and speed,
Samsung Biologics applies an optimized manufacturing framework across all sites
to ensure consistent execution throughout its global network.

Designed for Speed. Standardized for Reliability.

ExellenS™ drives faster regulatory readiness and tech transfer, supports seamless scalability, and strengthens quality and reliability across facilities. These aligned systems contribute to consistent outcomes and manufacturing efficiency supported by Analytical Testing and Quality Control.
  • Rapid approvals

    Equivalency across multiple plants accelerates regulatory approvals and supports regulatory readiness.
  • Predictable outcomes

    Consistent systems reduce risk and help ensure stable delivery of client programs.
  • Streamlined processes

    Standardized bioreactor configuration and aligned processes maximize efficiency and reproducibility.
  • Speed to market

    Agile tech transfers enable rapid scale-up and support faster product launches, leading directly into Drug Substance Manufacturing and Drug Product Manufacturing.
  • Data-driven insights

    Unified digital platforms support best-scenario modeling and data-driven decisions across development, including Analytical Development and Late Discovery.

Future-proof Your Pipeline with Scalable Platforms for Any Modality

Future-proof Your Pipeline with Scalable Platforms for Any Modality

With dual downstream capability and harmonized platforms, ExellenS™ enables fast-track technology transfers across plants while ensuring predictable, consistent delivery. The global biologics manufacturing network is built to accommodate diverse modalities, balance production schedules, and support multi-sourcing flexibility for stronger supply chain resilience. These capabilities extend to advanced modalities including mRNA therapeutics and Antibody-Drug Conjugates.

  • Built on Our
    Four Pillars of Excellence

    Predictable outcomes and risk reduction at every stage.

    Consistent, uncompromising quality aligned with the highest global standards.

    Optimized processes ensuring reliability, reproducibility, and flexibility.

    Highly trained professionals empowered by unified standards and systems to deliver high-quality results across programs and modalities.

  • Guided by the
    Three Structural Principles

    A unified blueprint across every plant, integrating identical facility design, digital processes, and seamless performance to support efficient technology transfer.

    Streamlined operations that minimize complexity, reduce risk, and enable faster tech transfers for greater efficiency.

    Global adaptability and integration of new capabilities, giving clients access to expanded capabilities without disruption.

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required